Skip to main content
Premium Trial:

Request an Annual Quote

BioFocus to Screen Schering-Plough Candidates

NEW YORK (GenomeWeb News) – Galapagos subsidiary BioFocus DPI will conduct drug discovery screening and targeting studies over a one-year period for Schering-Plough, Galapagos said today.

Under the €2.8 million ($4.1 million) agreement, BioFocus will perform medicinal chemistry and studies of absorption, distribution, excretion, and pharmacokinetics for multiple Schering-Plough projects at two sites in Europe.

The company said that the agreement with the Schering-Plough Research Institute builds on an earlier drug discovery project between the companies that was agreed upon in May of this year.

The Scan

Boosters Chasing Variants

The New York Times reports that an FDA advisory panel is to weigh updated booster vaccines for COVID-19.

Not Yet

The World Health Organization says monkeypox is not yet a global emergency, the Washington Post reports.

More Proposed for Federal Research

Science reports that US House of Representatives panels are seeking to increase federal research funding.

PLOS Papers on Breast Cancer Metastasis, Left-Sided Cardiac Defects, SARS-CoV-2 Monitoring

In PLOS this week: link between breast cancer metastasis and CLIC4, sequencing analysis of left-sided cardiac defects, and more.